- Filed
- May 6, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2026 · Apr 30, 2026 | 46.08M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2026 | 46.8M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2026 | 46.5M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2025 | 48.2M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2025 | 48.4M sh |
| Stock Repurchased | Q2 2026 · Mar 31, 2026 | $15.8M |
| Stock Repurchased | Q2 2026 · Mar 31, 2025 | $65.7M |
| Operating Cash Flow | Q2 2026 · Mar 31, 2026 | −$71.6M |
| Operating Cash Flow | Q2 2026 · Mar 31, 2025 | −$70.5M |
| Long Term Debt | Q2 2026 · Mar 31, 2026 | $1.24B |
| Long Term Debt | Q2 2026 · Sep 30, 2025 | $1.38B |
| Stockholders Equity | Q2 2026 · Mar 31, 2026 | $1.45B |
| Stockholders Equity | Q2 2026 · Dec 31, 2025 | $1.49B |
| Stockholders Equity | Q2 2026 · Sep 30, 2025 | $1.55B |
| Stockholders Equity | Q2 2026 · Mar 31, 2025 | $1.51B |
| Stockholders Equity | Q2 2026 · Dec 31, 2024 | $1.5B |
| Stockholders Equity | Q2 2026 · Sep 30, 2024 | $1.58B |
| Current Liabilities | Q2 2026 · Mar 31, 2026 | $613.8M |
| Current Liabilities | Q2 2026 · Sep 30, 2025 | $565.5M |
| Total Liabilities | Q2 2026 · Mar 31, 2026 | $2.09B |
| Total Liabilities | Q2 2026 · Sep 30, 2025 | $2.2B |
| Current Assets | Q2 2026 · Mar 31, 2026 | $1.11B |
| Current Assets | Q2 2026 · Sep 30, 2025 | $995.5M |
| Total Assets | Q2 2026 · Mar 31, 2026 | $3.53B |
| Total Assets | Q2 2026 · Sep 30, 2025 | $3.76B |
| Eps Diluted | Q2 2026 · Mar 31, 2026 | −$0.22 |
| Eps Diluted | Q2 2026 · Mar 31, 2026 | −$1.64 |
| Eps Diluted | Q2 2026 · Mar 31, 2025 | $0.60 |
| Eps Diluted | Q2 2026 · Mar 31, 2025 | $0.55 |
| Eps Basic | Q2 2026 · Mar 31, 2026 | −$0.23 |
| Eps Basic | Q2 2026 · Mar 31, 2026 | −$1.64 |
| Eps Basic | Q2 2026 · Mar 31, 2025 | $0.60 |
| Eps Basic | Q2 2026 · Mar 31, 2025 | $0.56 |
| Sga Expense | Q2 2026 · Mar 31, 2026 | $111M |
| Sga Expense | Q2 2026 · Mar 31, 2026 | $213.4M |
| Sga Expense restated | Q2 2026 · Mar 31, 2025 | $102.8M |
| Sga Expense restated | Q2 2026 · Mar 31, 2025 | $202.4M |
| Rd Expense | Q2 2026 · Mar 31, 2026 | $14.9M |
| Rd Expense | Q2 2026 · Mar 31, 2026 | $28.7M |
| Rd Expense restated | Q2 2026 · Mar 31, 2025 | $13.4M |
| Rd Expense restated | Q2 2026 · Mar 31, 2025 | $26.8M |
| Net Income | Q2 2026 · Mar 31, 2026 | −$10.6M |
| Net Income | Q2 2026 · Mar 31, 2026 | −$76.3M |
| Net Income | Q2 2026 · Dec 31, 2025 | −$65.7M |
| Net Income | Q2 2026 · Mar 31, 2025 | $29M |
| Net Income | Q2 2026 · Mar 31, 2025 | $26.9M |
| Net Income | Q2 2026 · Dec 31, 2024 | −$2.1M |
| Operating Income | Q2 2026 · Mar 31, 2026 | $18.4M |
| Operating Income | Q2 2026 · Mar 31, 2026 | −$500K |
| Operating Income restated | Q2 2026 · Mar 31, 2025 | $49M |
| Operating Income restated | Q2 2026 · Mar 31, 2025 | $58.3M |
| Gross Profit | Q2 2026 · Mar 31, 2026 | $216.9M |
| Gross Profit | Q2 2026 · Mar 31, 2026 | $377.9M |
| Gross Profit restated | Q2 2026 · Mar 31, 2025 | $236.9M |
| Gross Profit restated | Q2 2026 · Mar 31, 2025 | $409.4M |
| Cost Of Revenue | Q2 2026 · Mar 31, 2026 | $302.6M |
| Cost Of Revenue | Q2 2026 · Mar 31, 2026 | $564.4M |
| Cost Of Revenue restated | Q2 2026 · Mar 31, 2025 | $279.7M |
| Cost Of Revenue restated | Q2 2026 · Mar 31, 2025 | $522.3M |
| Revenue | Q2 2026 · Mar 31, 2026 | $519.5M |
| Revenue | Q2 2026 · Mar 31, 2026 | $942.3M |
| Revenue restated | Q2 2026 · Mar 31, 2025 | $516.6M |
| Revenue restated | Q2 2026 · Mar 31, 2025 | $931.7M |